NLRP3 inflammasome activation in sensory neurons promotes chronic inflammatory and osteoarthritis pain
Immunotherapy Advances · 01.01.2023 · 3 (1)
DOI: 10.1093/immadv/ltad022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunotherapy Advances, online erschienen am 24.10.2023. Verfasst von Patrícia Silva Santos Ribeiro und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Union’s Horizon 2020 research and innovation program, Netherlands Organization for Scientific Research.
Abstract (Originalsprache)
Pain is one of the most debilitating symptoms in rheumatic diseases. Pain often persists after total knee replacement in osteoarthritis, or when inflammation is minimal/absent in rheumatoid arthritis. This suggests that pain transitions to a chronic state independent of the original damage/inflammation. Mitochondrial dysfunction in the nervous system promotes chronic pain and is linked to NLRP3 inflammasome activation. Therefore, we investigated the role of mitochondrial dysfunction and NLRP3 inflammasome activation in the transition from acute to persistent inflammation-induced nociplastic pain and in persistent monoiodoacetate-induced osteoarthritis pain. Intraplantar injection of carrageenan in mice induced transient inflammatory pain that resolved within 7 days. A subsequent intraplantar PGE2 injection induced persistent mechanical hypersensitivity, while in naive mice it resolved within one day. Thus, this initial transient inflammation induced maladaptive nociceptor neuroplasticity, so-called hyperalgesic priming. At Day 7, when mice were primed, expression of NLRP3 inflammasome pathway components was increased, and dorsal root ganglia (DRG) neurons displayed signs of activated NLRP3 inflammasome. Inhibition of NLRP3 inflammasome with MCC950 prevented the transition from acute to chronic pain in this hyperalgesic priming model. In mice with persistent monoiodoacetate-induced osteoarthritis pain, DRG neurons displayed signs of mitochondrial oxidative stress and NLRP3 inflammasome activation. Blocking NLRP3 inflammasome activity attenuated established osteoarthritis pain. In males, NLPR3 inhibition had longer-lasting effects than in females. Overall, these data suggest that NLRP3 inflammasome activation in sensory neurons, potentially caused by neuronal oxidative stress, promotes development of persistent inflammatory and osteoarthritis pain. Therefore, targeting NLRP3 inflammasome pathway may be a promising approach to treat chronic pain.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
ORCID-Profile: Patrícia Silva Santos Ribeiro, Hanneke L D M Willemen, Niels Eijkelkamp
Förderung
- European Union’s Horizon 2020 research and innovation program
- Netherlands Organization for Scientific Research
Zitieren
APA
Silva Santos Ribeiro, P., Willemen, H. L. D. M., Versteeg, S., Martin Gil, C., & Eijkelkamp, N. (2023). NLRP3 inflammasome activation in sensory neurons promotes chronic inflammatory and osteoarthritis pain. Immunotherapy Advances, 3(1). https://doi.org/10.1093/immadv/ltad022
Vancouver
Silva Santos Ribeiro P, Willemen HLDM, Versteeg S, Martin Gil C, Eijkelkamp N. NLRP3 inflammasome activation in sensory neurons promotes chronic inflammatory and osteoarthritis pain. Immunotherapy Advances. 2023;3(1). doi:10.1093/immadv/ltad022
BibTeX
@article{SilvaSantosRibeiro2023,
author = {Silva Santos Ribeiro, Patrícia and Willemen, Hanneke L D M and Versteeg, Sabine and Martin Gil, Christian and Eijkelkamp, Niels},
title = {NLRP3 inflammasome activation in sensory neurons promotes chronic inflammatory and osteoarthritis pain},
journal = {Immunotherapy Advances},
year = {2023},
volume = {3},
number = {1},
doi = {10.1093/immadv/ltad022}
}
EUVIMED